Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET/MRI Evaluation in Patients With Primary Sclerosing Cholangitis Using Intercellular Matrix Radiopharmaceuticals

NCT06252610 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06252610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06252610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET/MRI Evaluation in Patients With Primary Sclerosing Cholangitis Using Intercellular Matrix Radiopharmaceuticals
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
December 10, 2026
Completion date
April 30, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psc